
Experience
TBO to Acquire Classic Vacations From the Najafi Companies
September 3, 2025
Cooley advised TBO, a leading global travel distribution platform, on its agreement to acquire Classic Vacations from Arizona-based investment firm, the Najafi Companies.
Related contacts
Related Practices & Industries
Thirty Madison to Be Acquired by Remedy Meds
September 3, 2025
Cooley advised Thirty Madison, a specialty healthcare company offering high-quality virtual specialized care for patients experiencing a range of conditions, on its definitive agreement to be acquired by Remedy Meds in an all-stock transaction valued in excess of $500 million.
Related contacts
Related Practices & Industries
Cooley Advises Investor Syndicate on $2.25 Billion Acquisition of HistoSonics
August 7, 2025
Cooley advised a syndicate of globally recognized private and public investors in connection with the management-led majority stake acquisition of HistoSonics, the developer of the Edison Histotripsy System and novel histotripsy therapy platform, valuing the company at approximately $2.25 billion.
Related contacts
Related Practices & Industries
Red Canary Announces Acquisition by Zscaler
May 27, 2025
Cooley advised Red Canary, a top managed detection and response platform that investigate threats while streamlining workflows through automated remediation, on its acquisition by Zscaler (Nasdaq: ZS).
Related contacts
Related Practices & Industries
Araris Biotech’s up to $1.14 Billion Acquisition by Taiho Pharmaceutical
March 17, 2025
Cooley advised Araris Biotech, a Swiss biotechnology company developing next-generation antibody-drug conjugates, on its definitive agreement to be acquired by Japan-based Taiho Pharmaceutical for up to $1.14 billion in cash.
Related contacts
Related Practices & Industries
Related news and events
Cooley Advises Investor Syndicate on $2.25 Billion Acquisition of HistoSonics
Admissions and credentials
New York